XSHE
300146
Market cap2.85bUSD
Dec 05, Last price
11.92CNY
1D
0.34%
1Q
-2.61%
Jan 2017
-0.17%
IPO
98.80%
Name
Byhealth Co Ltd
Chart & Performance
P/E
30.89
P/S
2.95
EPS
0.39
Div Yield, %
7.55%
Shrs. gr., 5y
2.99%
Rev. gr., 5y
5.38%
Revenues
6.84b
-27.30%
Net income
653m
-62.62%
CFO
686m
-66.56%
Dividend
Apr 22, 20240.9 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
By-health Co., Ltd. produces and sells dietary supplements worldwide. The company offers proteins and vitamins/minerals; and various products for skeleton and joints, heart and cerebral vessels, beauty maintenance, immunity boosting, weight management, vigor enhancement, eye nutrition, sleep improvement, blood glucose management, memory improvement, reproductive health, childhood nutrition, and pregnant women nutrition, as well as for liver, intestines, and stomach. It provides its products for children, men, women, and elderly people under the By-health and GymMax brand names through distributors, retail terminals, and online channels. The company was formerly known as Guangdong By-Health Biotechnology Co., Ltd. and changed its name to By-health Co., Ltd. in April 2012. By-health Co., Ltd. was founded in 1995 and is headquartered in Guangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||